<DOC>
	<DOC>NCT02874144</DOC>
	<brief_summary>To evaluate the efficacy of an anti-inflammatory agent compared with placebo in relieving signs and symptoms of disease in patients with sinusitis.</brief_summary>
	<brief_title>Anti-Inflammatory Agent in Sinusitis</brief_title>
	<detailed_description>This is a Phase 2a, single-center, randomized, placebo-controlled, double-blind study that includes 12 weeks of treatment with experimental drug anti-inflammatory agent or placebo TID administered orally. All subjects will be â‰¥18 years, have sinusitis with persistent symptoms despite standard of care treatment, and have failed a course of steroids in the past.</detailed_description>
	<mesh_term>Sinusitis</mesh_term>
	<mesh_term>Nasal Polyps</mesh_term>
	<mesh_term>Anti-Inflammatory Agents</mesh_term>
	<criteria>1. Females must have a negative urine pregnancy test at screening unless documented to have a hysterectomy or be postmenopausal. 1. Inability or unwillingness of a participant to give written informed consent or comply with study protocol 2. Use of any investigational drugs within 30 days of screening. 3. Acute infection needing antibiotic treatment at screening.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>August 2016</verification_date>
</DOC>